Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting CTGF in Cancer: An Emerging Therapeutic Opportunity

Published:2021-06 Issue:6 Volume:7 Page:511-524
ISSN:2405-8033
Container-title:Trends in Cancer
language:en
Short-container-title:Trends in Cancer

Author:

Shen Yi-Wen,Zhou Yu-Dong,Chen Hong-Zhuan,Luan Xin,Zhang Wei-Dong

Funder

Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference104 articles.

1. Connective tissue growth factor: a cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10;Bradham;J. Cell Biol.,1991

2. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets;Jun;Nat. Rev. Drug Discov.,2013

3. Connective tissue growth factor (CTGF) from basics to clinics;Ramazani;Matrix Biol.,2018

4. The CCN family: a new class of inflammation modulators?;Kular;Biochimie,2011

5. Therapeutic potential of connective tissue growth factor (CTGF) in triple-negative breast cancer;Kim;Ann. Oncol.,2019

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The role of Hippo/YAP1 in cancer-associated fibroblasts: Literature review and future perspectives;Cancer Letters;2024-11

2. Identification of key genes and pathways involved in T-DM1-resistance in OE-19 esophageal cancer cells through bioinformatics analysis;Heliyon;2024-09

3. Spatial multiomics reveals a subpopulation of fibroblasts associated with cancer stemness in human hepatocellular carcinoma;Genome Medicine;2024-08-13

4. The novel thromboxane prostanoid receptor mediates CTGF production to drive human nasal fibroblast self‐migration through NF‐κB and PKCδ‐CREB signaling pathways;Journal of Cellular Physiology;2024-08-05

5. Targeting the Hippo/YAP1 signaling pathway in hepatocellular carcinoma: From mechanisms to therapeutic drugs (Review);International Journal of Oncology;2024-07-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3